• Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
eXoZymes
Home

Technology

The platform Artificial Intelligence BioClick Scientific papers

Pipeline

Pipeline overview NCT: Over-the-Counter NCT: Pharma Cannabinoids Santalene

Investors

Stock information SEC Filings Email signup

About

About eXoZymes Jobs News
  1. Home
  2. investors

Category

investors

12 videos

Investor Presentation by Chris Marlett (May 2026)
investors
Investor Presentation by Chris Marlett (May 2026) May 11, 2026 · 313 views
eXoZymes Investor Presentation (April 2026)
investors
eXoZymes Investor Presentation (April 2026) April 18, 2026 · 223 views
NCT presentation by Damien Perriman, CCO
investors
NCT presentation by Damien Perriman, CCO April 03, 2026 · 153 views
Nasdaq: Damien Perriman interview on NCT
investors
Nasdaq: Damien Perriman interview on NCT April 02, 2026 · 161 views
EXOZ Investor Update - Q4+2025 (March 31. 2026)
investors
EXOZ Investor Update - Q4+2025 (March 31. 2026) April 01, 2026 · 1,250 views
Interview: Cayman Chemical validates eXoZymes' technology and scalability
investors
Interview: Cayman Chemical validates eXoZymes' technology and scalability March 18, 2026 · 443 views
Rapid Scale-Up: Enzyme Breakthrough Achieved! (01)
investors
Rapid Scale-Up: Enzyme Breakthrough Achieved! (01) March 18, 2026 · 38 views
Lou Basenese: CEO spotlights
investors
Lou Basenese: CEO spotlights March 02, 2026 · 50 views
Chief Scientific Officer, Tyler Korman, PhD
investors
Chief Scientific Officer, Tyler Korman, PhD November 14, 2025 · 79 views
NCT: Damien on 4 grams of NCT with over 99% purity
investors
NCT: Damien on 4 grams of NCT with over 99% purity July 29, 2025 · 157 views
NCT: From concept to gram-scale quantity in only 5 months
investors
NCT: From concept to gram-scale quantity in only 5 months July 22, 2025 · 181 views
Slack Capital interview: Damien Perriman, CCO
investors
Slack Capital interview: Damien Perriman, CCO May 21, 2025 · 101 views
  • 1
  • 2
  • 3
  • Next

eXoZymes Inc.

750 Royal Oaks Dr, st 106, 
Monrovia 91016, CA, USA

P: (626) 415-1488
E: info@exozymes.com

 

© eXoZymes Inc. [Nasdaq:EXOZ] unshackling enzymes since 2019 (formerly known as Invizyne Technologies)

Videos Webinars Investors SEC Filings Privacy Policy Terms of Use